Venture capital heavyweight Jim Breyer has made billions placing the right bets on start-ups – including on Facebook. Now he is backing Australian telehealth company Rosemary Health, which is seeking to disrupt the primary care and prescription drugs market.
After nearly 28 years at US venture firm Accel, Mr Breyer now invests through his namesake firm. He has invested in over 40 companies that have had successful IPOs or mergers including Etsy, Marvel Entertainment and Legendary Entertainment.
Loading...
Carrie LaFrenz is a senior journalist covering retail/consumer goods. She previously covered healthcare/biotech. Carrie has won multiple awards for her journalism including financial journalist of the year from The National Press Club. Connect with Carrie on Twitter. Email Carrie at carrie.lafrenz@afr.com
